XML 21 R9.htm IDEA: XBRL DOCUMENT v3.24.1
FAIR VALUE MEASUREMENTS
12 Months Ended
Dec. 31, 2023
FAIR VALUE MEASUREMENTS [Abstract]  
FAIR VALUE MEASUREMENTS
NOTE 3 - FAIR VALUE MEASUREMENTS

The Company’s cash, cash equivalents and marketable securities are stated at fair value. The carrying value of accounts receivable, other current assets, accrued expenses, and accounts payable approximates fair market value because of the short maturity of these financial instruments.

The Company’s cash equivalents are generally classified within Level 1 of the fair value hierarchy because they are valued using quoted market prices.

All held-to-maturity securities investments as of December 31, 2023 were US treasury and federal bonds. Investments in these bonds are based on quoted market prices in active markets, and are included in the Level 1 fair value hierarchy.

The tables below set forth the Company’s cash and cash equivalents, as well as marketable securities as of December 31, 2023 and 2022, respectively, which are measured at fair value on a recurring basis by level within the fair value hierarchy.

   
December 31, 2023
 
   
Level 1
   
Level 2
   
Level 3
   
Total
 
                         
Cash and cash equivalents
 
$
11,004,937
   
$
-
   
$
-
   
$
11,004,937
 
Held-to-maturity securities
    4,194,958       -       -       4,194,958  

  $
15,199,895     $
-     $
-     $
15,199,895  

   
December 31, 2022
 
   
Level 1
   
Level 2
   
Level 3
   
Total
 
                         
Cash and cash equivalents
 
$
9,866,628
   
$
-
   
$
-
   
$
9,866,628
 
Held-to-maturity securities     4,028,565       -       -       4,028,565  

  $ 13,895,193     $ -     $ -     $ 13,895,193  

The Company did not hold financial assets and liabilities which were recorded at fair value in the Level 2 or 3 categories as of December 31, 2023.

The preceding methods may produce a fair value calculation that may not be indicative of net realizable value or reflective of future fair values. Furthermore, although the Company believes its valuation methods are appropriate and consistent with other market participants, the use of different methodologies or assumptions to determine the fair value of certain financial instruments could result in a different fair value measurement at the reporting date.